^
Association details:
Biomarker:No biomarker
Cancer:Breast Cancer
Drug:anastrozole (Aromatase inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
Source:
Published date:
12/13/2018
Excerpt:
ARIMIDEX is an aromatase inhibitor indicated for:...First-line treatment of postmenopausal women with hormone receptorpositive or hormone receptor unknown locally advanced or metastatic breast cancer.